145 related articles for article (PubMed ID: 7897635)
21. Missense mutations affecting a conserved cysteine pair in the TH domain of Btk.
Vihinen M; Nore BF; Mattsson PT; Bäckesjö CM; Nars M; Koutaniemi S; Watanabe C; Lester T; Jones A; Ochs HD; Smith CI
FEBS Lett; 1997 Aug; 413(2):205-10. PubMed ID: 9280283
[TBL] [Abstract][Full Text] [Related]
22. Twin carriers of X-linked agammaglobulinemia (XLA) due to germline mutation in the Btk gene.
Curtis SK; Hebert MD; Saha BK
Am J Med Genet; 2000 Jan; 90(3):229-32. PubMed ID: 10678660
[TBL] [Abstract][Full Text] [Related]
23. Point mutation in intron 11 of Bruton's tyrosine kinase in atypical X-linked agammaglobulinemia.
Shinomiya N; Kanegane H; Watanabe A; Yamaguchi Y; Futatani T; Miyawaki T
Pediatr Int; 2000 Dec; 42(6):689-92. PubMed ID: 11192530
[No Abstract] [Full Text] [Related]
24. B-cell-specific demethylation of BTK, the defective gene in X-linked agammaglobulinemia.
Parolini O; Rohrer J; Shapiro LH; Conley ME
Immunogenetics; 1995; 42(2):129-35. PubMed ID: 7541776
[TBL] [Abstract][Full Text] [Related]
25. Female agammaglobulinemia due to the Bruton tyrosine kinase deficiency caused by extremely skewed X-chromosome inactivation.
Takada H; Kanegane H; Nomura A; Yamamoto K; Ihara K; Takahashi Y; Tsukada S; Miyawaki T; Hara T
Blood; 2004 Jan; 103(1):185-7. PubMed ID: 12958074
[TBL] [Abstract][Full Text] [Related]
26. Bruton's tyrosine kinase mutations in 8 Chinese families with X-linked agammaglobulinemia.
Yip KL; Chan SY; Ip WK; Lau YL
Hum Mutat; 2000 Apr; 15(4):385. PubMed ID: 10737994
[TBL] [Abstract][Full Text] [Related]
27. BTKbase: a database of XLA-causing mutations. International Study Group.
Vihinen M; Cooper MD; de Saint Basile G; Fischer A; Good RA; Hendriks RW; Kinnon C; Kwan SP; Litman GW; Notarangelo LD
Immunol Today; 1995 Oct; 16(10):460-5. PubMed ID: 7576047
[No Abstract] [Full Text] [Related]
28. Molecular and structural characterization of five novel mutations in the Bruton's tyrosine kinase gene from patients with X-linked agammaglobulinemia.
Saha BK; Curtis SK; Vogler LB; Vihinen M
Mol Med; 1997 Jul; 3(7):477-85. PubMed ID: 9260159
[TBL] [Abstract][Full Text] [Related]
29. The spectrum of mutations in Btk that cause X-linked agammaglobulinemia.
Conley ME; Rohrer J
Clin Immunol Immunopathol; 1995 Sep; 76(3 Pt 2):S192-7. PubMed ID: 7554467
[No Abstract] [Full Text] [Related]
30. X-linked agammaglobulinemia and Bruton's tyrosine kinase.
Tsukada S; Witte ON
Adv Exp Med Biol; 1994; 365():233-8. PubMed ID: 7887309
[No Abstract] [Full Text] [Related]
31. The genomic structure of human BTK, the defective gene in X-linked agammaglobulinemia.
Rohrer J; Parolini O; Belmont JW; Conley ME; Parolino O [corrected to Parolini O]
Immunogenetics; 1994; 40(5):319-24. PubMed ID: 7927535
[TBL] [Abstract][Full Text] [Related]
32. Stability and peptide binding specificity of Btk SH2 domain: molecular basis for X-linked agammaglobulinemia.
Tzeng SR; Pai MT; Lung FD; Wu CW; Roller PP; Lei B; Wei CJ; Tu SC; Chen SH; Soong WJ; Cheng JW
Protein Sci; 2000 Dec; 9(12):2377-85. PubMed ID: 11206059
[TBL] [Abstract][Full Text] [Related]
33. BTKbase, mutation database for X-linked agammaglobulinemia (XLA).
Vihinen M; Brandau O; Brandén LJ; Kwan SP; Lappalainen I; Lester T; Noordzij JG; Ochs HD; Ollila J; Pienaar SM; Riikonen P; Saha BK; Smith CI
Nucleic Acids Res; 1998 Jan; 26(1):242-7. PubMed ID: 9399844
[TBL] [Abstract][Full Text] [Related]
34. X linked agammaglobulinaemia with a 'leaky' phenotype.
Jones A; Bradley L; Alterman L; Tarlow M; Thompson R; Kinnon C; Morgan G
Arch Dis Child; 1996 Jun; 74(6):548-9. PubMed ID: 8758136
[TBL] [Abstract][Full Text] [Related]
35. X-linked agammaglobulinemia: lack of mature B lineage cells caused by mutations in the Btk kinase.
Smith CI; Bäckesjö CM; Berglöf A; Brandén LJ; Islam T; Mattsson PT; Mohamed AJ; Müller S; Nore B; Vihinen M
Springer Semin Immunopathol; 1998; 19(4):369-81. PubMed ID: 9618763
[No Abstract] [Full Text] [Related]
36. Unusual patterns of exon skipping in Bruton tyrosine kinase are associated with mutations involving the intron 17 3' splice site.
Haire RN; Ohta Y; Strong SJ; Litman RT; Liu Y; Prchal JT; Cooper MD; Litman GW
Am J Hum Genet; 1997 Apr; 60(4):798-807. PubMed ID: 9106525
[TBL] [Abstract][Full Text] [Related]
37. Structure of the PH domain and Btk motif from Bruton's tyrosine kinase: molecular explanations for X-linked agammaglobulinaemia.
Hyvönen M; Saraste M
EMBO J; 1997 Jun; 16(12):3396-404. PubMed ID: 9218782
[TBL] [Abstract][Full Text] [Related]
38. X-chromosome inactivation and mutation pattern in the Bruton's tyrosine kinase gene in patients with X-linked agammaglobulinemia. Italian XLA Collaborative Group.
Moschese V; Orlandi P; Plebani A; Arvanitidis K; Fiorini M; Speletas M; Mella P; Ritis K; Sideras P; Finocchi A; Livadiotti S; Rossi P
Mol Med; 2000 Feb; 6(2):104-13. PubMed ID: 10859027
[TBL] [Abstract][Full Text] [Related]
39. Mutation analysis in Bruton's tyrosine kinase, the X-linked agammaglobulinaemia gene, including identification of an insertional hotspot.
Gaspar HB; Bradley LA; Katz F; Lovering RC; Roifman CM; Morgan G; Levinsky RJ; Kinnon C
Hum Mol Genet; 1995 Apr; 4(4):755-7. PubMed ID: 7633429
[No Abstract] [Full Text] [Related]
40. Mutation analysis of the gene encoding Bruton's tyrosine kinase in a family with a sporadic case of X-linked agammaglobulinemia reveals three female carriers.
Hagemann TL; Assa'ad AH; Kwan SP
Am J Med Genet; 1995 Nov; 59(2):188-92. PubMed ID: 8588584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
